Condition: Gastroesophageal Reflux · Sponsor: Helse Forde
The goal of this clinical trial is to test gastropexy as a measure to reduce reflux in morbidly obese patients being submitted to sleeve gastrectomy. The main questions it aims to answer are: Does gastropexy reduce reflux symptoms? Does gastropexy reduce objective evidence of reflux? Participants will be randomized to gastropexy or no gastropexy, and researchers will compare these groups to see if reflux (symptoms / objective evidence of) is different in the two groups.
This description comes directly from the study's public registry record.
Villy Vage, MD PhD · 47 90863744 · villy.vage@helse-bergen.no
John Andersen, PhD · 47 48278186 · john.roger.andersen@helse-forde.no
Always discuss trial participation with your own doctor first.
| Helse Forde | Førde, Norway | Not Yet Recruiting |
| Aleris Oslo | Oslo, Norway | Recruiting |
| Volda sjukehus | Volda, Norway | Recruiting |
| Voss sjukehus | Voss, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05704348